# ยง 316.28   Publication of orphan-drug designations.

Each month FDA will update a publicly available cumulative posting of all drugs designated as orphan drugs. These postings will contain the following information:


(a) The name and address of the sponsor;


(b) The generic name and trade name, if any, or, if neither is available, the chemical name or a meaningful descriptive name of the drug;


(c) The date of the granting of orphan-drug designation;


(d) The designated use in the rare disease or condition; and


(e) If the drug loses designation after August 12, 2013, the date of it no longer having designation.



---

[N] [78 FR 35134, June 12, 2013]




